Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Mitraltech Ltd News
Mitraltech Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mitraltech Ltd. Real-time updates on events, politics, business and more.
Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
HANGZHOU, China, Jan. 25, 2022 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural he...
Source: businessinsider.com
Venus Medtech (Hangzhou) Inc.: Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
HANGZHOU, China, Jan. 26, 2022 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its
Source: finanznachrichten.de
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
/CNW/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...
Source: newswire.ca
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...
Source: prnewswire.com
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...
Source: prnewswire.com
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
Venus Medtech ( Hangzhou ) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve),
Source: medindia.net
Venus Medtech (Hangzhou) Inc.: Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its
Source: finanznachrichten.de
China's Venus Medtech buys Israeli co Cardiovalve
Venus Medtech will pay $150 million immediately and a further $150 million dependent on reaching regulatory milestones.
United States Amir Gross Edwards Lifesciences Venus Medtech Venus Medtech Hangzhou Inc Boston Scientific
Source: globes.co.il